Newsroom | 9200 results

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with the American Heart Association, the world’s leading nonprofit organization focused on heart and brain health, to support cardiovascular disease awareness, prevention, and community health initiatives. “New data from the American Heart Association shows that cardiovascular disease continues to take an enormous toll on families and communities,” said Kristen Eisenhau...

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only leadless left ventricular endocardial pacing (LVEP) system for heart failure, today announced its participation in the Heart Rhythm 2026 conference, taking place April 23-26, 2026, in Chicago, IL. EBR will have a strong presence at the conference, including an exhibit booth showcasing the WiSE® System and participation in multiple scientific sessions. The following talks are sponsored by EBR: Real World Experie...

COLUMBIA, Md. & BALTIMORE, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced a strategic partnership with b.well Connected Health, whose health data management platform powers the nation’s largest consumer-mediated health data network, connecting nearly 2.4 million providers and 350 health plans. Through this partnership, Welldoc gains access to patient-authorized health data at an unprecedented scale, enabling more complete, personalized i...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has been ranked No. 1 in the Black Book Research survey of AI Clinical Decision Support solutions for the second consecutive year. Based on direct feedback from 1,237 healthcare professionals, including clinicians, administrators, and operational leaders across hospitals, health systems, and medical groups, the annual Black Book survey evaluates vendors on ent...

GUILFORD, Conn.--(BUSINESS WIRE)--Next-gen Swoop system and latest Optive AI software receive CE & UKCA marks, bringing Hyperfine’s most advanced portable MRI tech to European markets....

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced several Board and governance updates, including the nomination of Michael J. Tokich to the Board of Directors, its intent to establish a new Growth and Operating Committee of the Board and its plan to commence share repurchases under the Company’s previously announced program ahead of schedule. The announcements reflect the Board’s continued focus on strong governanc...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana announced US FDA clearance of its ECG-AI™ algorithm for cardiac amyloidosis....

BOSTON--(BUSINESS WIRE)--Etiometry, a leader in AI-driven clinical intelligence, today announced it has received FDA clearance (K254066) for the first-ever solution for automation of hospital-specific cardiogenic shock classification and tracking by directly utilizing data from physiologic monitoring, the Etiometry Cardiogenic Shock Tool. Cardiogenic shock remains a critical challenge, with delayed identification contributing to poor outcomes and persistently high mortality rates, despite advan...

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to expand the Company’s FULCRUM-VT trial to evaluate the safety and effectiveness of the Company’s next-generation vCLAS Ultra-Low Temperature Ablation (ULTA) Ventri...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to the company’s investigational miroliverELAP®, an external liver assist product. Developed by Miromatrix Medical Inc., a wholly owned subsidiary of United Therapeutics, miroliverELAP consists of an external blood cir...